Patent Assignment
Reel/Frame 067084/0441
Assignment of Assignor's Interest
Recorded: 2024-04-12
Pages: 3
Assignor
ERLANSON, DANIEL
Executed: 2011-01-04
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Heterocyclic Compounds Useful as PDK1 Inhibitors
Application:
18/632,638 →
Publication:
US 2024/0294524
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 12, 2024
From: ARNDT, JOSEPH; CHAN, TIMOTHY; KUMARAVEL, GNANASAMBANDAM; GUCKIAN, KEVIN
To: BIOGEN IDEC MA INC.
Reel/Frame 067084/0444 →
Assignment of Assignor's Interest
Apr 12, 2024
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 067084/0462 →
Change of Name
Apr 12, 2024
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 067097/0226 →
Intellectual Property Security Agreement
Jan 23, 2025
From: VIRACTA THERAPEUTICS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 070000/0010 →